CPRX•benzinga•
Catalyst Pharmaceuticals Sees FY24 Revenue $475M-$485M Vs $473.67 Est.
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 6, 2024 by benzinga